Summary:
- The FDA has cleared Medtronic's MiniMed 780G system, which is an advanced insulin pump that can automatically adjust insulin delivery based on glucose levels.
- The system is now approved for use in people with type 2 diabetes, in addition to those with type 1 diabetes.
- The MiniMed 780G system can now integrate with Abbott's Instinct continuous glucose monitoring sensor, allowing for seamless data sharing and improved diabetes management.